Combination cell therapy leads to clonal deletion of donor-specific T cells in kidney transplant recipients.
David AF, Heinzel A, Kammer M, Aschauer C, Reindl-Schwaighofer R, Hu K, Chen HS, Muckenhuber M, Kubetz A, Weijler AM, Worel N, Edinger M, Berlakovich G, Lion T, Sykes M, Wekerle T, Oberbauer R.
David AF, et al.
EBioMedicine. 2024 Aug;106:105239. doi: 10.1016/j.ebiom.2024.105239. Epub 2024 Jul 13.
EBioMedicine. 2024.
PMID: 38996766
Free PMC article.
Clinical Trial.